This issue of the Cardiac Electrophysiology Clinics, edited by Drs. Amin Al- Ahmad and Francis Marchlinski, will cover Ventricular Tachycardia in Structural Heart Disease. Topics discussed in the issue include, but are not limited to, ECG localization of VT in patients with structural heart disease; Anatomy for VT ablation in structural heart disease; Ablation of VT in ischemic and non-ischemic heart disease; Pace mapping; Ablation of VT in ARVD; Epicardial VT ablation; and VT clinical trials, among others.

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original "AID" device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the "more sinusoidal waveform of ventricular fibrillation. " The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by "Arrhythmia Management Devices" were designed to reduce the "arrhytlunia burden" and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.

The second edition of this bestseller provides a practical, user-friendly manual guiding the theory and practice of cardiac electrophysiology. The handbook provides the specialist in training with a thorough grounding procedures, and clinical findings for clinicians. It provides a review of the main kinds of arrhythmia with illustrations of typical ECG findings supported where appropriate by correlative imaging. It also details the principal diagnostic and therapeutic procedures include implantation of pacemakers, resynchronization therapy, and ablation techniques. Key Features Provides concise, user friendly guide to the equipment, procedures and clinical findings with which EPs need to be familiar Delivers alternatives resource to the flagship titles available in this field - idea for those beginning training or seeking an update Presents extensively updated material to enhance comprehension Includes new treatments and devices for electrophysiologists trained to perform interventional cardiac electrophysiology studies (EPS) as well as surgical device implantations

In collaboration with the Consulting Editors, Ranjan K. Thakur and Andrea Natale, Drs. Luigi Di Biase, Frank Marchlinski, and Andrea Natale have assembled an issue of Cardiac Electrophysiology Clinics on Advances in Atrial Fibrillation Ablation. Topics include, but are not limited to, Recurrent atrial fibrillation with isolated PVs, Beyond PVI in non paroxysmal atrial fibrillation, Recurrent atrial fibrillation after cryo, Recurrent atrial fibrillation after RF, high-density mapping, Expectation and Results of surrogate target beyond PVI, Lessons from epicardial mapping and ablation in refractory atrial fibrillation, Evolution of radiofrequency ablation parameters, Balloon based technologies, Energy sources, Current status of esophageal protection, Fluoroless atrial fibrillation ablation, Role of MRI imaging before and after ablation, When to stop OAC after atrial fibrillation ablation, Atrial fibrillation ablation trials, Risk Factor modification before and after atrial fibrillation ablation.

The second edition of this bestseller provides a practical, user-friendly manual guiding the theory and practice of cardiac electrophysiology. The handbook provides the specialist in training with a thorough grounding procedures, and clinical findings for clinicians. It provides a review of the main kinds of arrhythmia with illustrations of typical ECG findings supported where appropriate by correlative imaging. It also details the principal diagnostic and therapeutic procedures include implantation of pacemakers, resynchronization therapy, and ablation techniques. Key Features Provides concise, user friendly guide to the equipment, procedures and clinical findings with which EPs need to be familiar Delivers alternatives resource to the flagship titles available in this field - idea for those beginning training or seeking an update Presents extensively updated material to enhance comprehension Includes new treatments and devices for electrophysiologists trained to perform interventional cardiac electrophysiology studies (EPS) as well as surgical device implantations

Implantable defibrillators as originally conceived by Michel Mirowski were limited to the detection and automatic termination of ventricular fibrillation. In the original "AID" device, the detection algoritlun sought to distinguish sinus rhytlun from ventricular fibrillation by identifying the "more sinusoidal waveform of ventricular fibrillation. " The therapeutic intervention was elicited only once deadly polymorphic rhythms had developed. It was rapidly learned, however, that ventricular fibrillation is usually preceded by ventricular tachycardia. Mirowski recognized the pivotal importance of developing algoritllms based on heart rate. Ventricular tachycardia detection allowed the successful development of interventions for the termination of ventricular tachyarrhythmias before they degenerated into ventricular fibrillation. Current device therapy no longer confines itself to tlle termination of chaotic rhythms but seeks to prevent them. Diagnostic algorithms moved upward along the chain of events leading to catastrophic rhytlulls. Rate smoothing algorithms were developed to prevent postextrasystolic pauses from triggering ventricular and atrial tachyarrhytlmlias. Beyond the renaissance of ectopy-centered strategies, long-term prevention received increasing attention. Multisite pacing therapies provided by "Arrhythmia Management Devices" were designed to reduce the "arrhytlunia burden" and optimize the synergy of cardiac contraction and relaxation. Clinical evidence now suggests that atrial fibrillation prevention by pacing is feasible and tllat biventricular pacing may be of benefit in selected patients with heart failure. However, these applications of device therapy that generally require ventricular defibrillation backup remain investigational and were not considered in this book.